and the Recombinate and Kogenate Study Groups. Determination of anti-factor VIII antibodies responsible for the inhibitor titer in hemophiliacs treated with plasma or recombinant factor VIII and in spontaneous inhibitors - Scandella, D; Nakai, H; Felch, M; Prescott, R; Bray, G; Hurst, D (Blood, 1994)
(abstr)